Enter your terms above and click the 'Search' button.

Showing articles 0 to 6 of 6 Filter Applied: multiple sclerosis,treatment of (Click to remove) Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008 Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis NEJM 376:221-234,280, Hauser, S.L.,et al, 2017 Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis NEJM 376:209-220,280, Montalban, X.,et al, 2017 Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011 Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009 B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis NEJM 358:676-688, Hauser,S.L.,et al, 2008 Showing articles 0 to 6 of 6